Our Services
Based on organoid technology
Our services is based on organoid technology and includes disease model development and biobanking for a range of disease, drug screening and clinical trials in a dish (CTiD) platform for preclinical patient stratification and personalized medicine approaches.
Disease Model Development
We can support your drug testing needs for a variety of disease areas where clinically relevant disease models are yet to be developed.
Drug Screening Assays
A wide range of standard in vitro assays typically used in compound testing such as the evaluation of cell viability & cytotoxicity for drug efficacy and toxicity screens, immunohistochemistry and immunofluorescence imaging, gene expression profiling (protein and mRNA), FACS analysis and DNA/RNA seq.
Drug screening platform – clinical trials in a dish (CTiD)
Our living organoid biobank includes more than 20 different organoid models representing a variety of organs and disease types. Your selected models from our biobank can be enrolled in Clinical Trials in a Dish (CTiD).